Overview
R Cornelissen practices in Rotterdam, Netherlands. Cornelissen is rated as an Experienced expert by MediFind in the treatment of Small Cell Lung Cancer (SCLC). Their top areas of expertise are Mesothelioma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer.
Their clinical research consists of co-authoring 72 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Small Cell Lung Cancer (SCLC).
Locations
Rotterdam, ZH, Netherlands
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- MesotheliomaCornelissen isElite. Learn about Mesothelioma.
- Distinguished
- Lung CancerCornelissen isDistinguished. Learn about Lung Cancer.
- Advanced
- Non-Small Cell Lung Cancer (NSCLC)Cornelissen isAdvanced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Experienced
- Anal CancerCornelissen isExperienced. Learn about Anal Cancer.
- EGFR Positive Lung CancerCornelissen isExperienced. Learn about EGFR Positive Lung Cancer.
- Pleural EffusionCornelissen isExperienced. Learn about Pleural Effusion.
- Small Cell Lung Cancer (SCLC)Cornelissen isExperienced. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaCornelissen isExperienced. Learn about Squamous Cell Lung Carcinoma.